Summary
Introduction
Gilbert's syndrome is a familial disorder of bilirubin metabolism involving one or more steps in the handling of bilirubin by the liver [l]. Studies have attributed the hyperbilirubinaemia variously to a defect in hepatic uptake and conjugation [2, 31 and to a defect of UDPglucuronyltransferase activity (4-61; a decreased proportion of bilirubin diglucuronide in the bile has been described as a consequence of the impaired bilirubin metabolism [7, 81. The syndrome has also been associated with defects inducing a rise in turnover of erythrocyte haem, such as mild haemolysis escaping clinical detection 19-1 11.
Although abnormalities in bilirubin metabolism in Gilbert's syndrome have been extensively investigated, relatively little attention has been
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paid to the hepatic turnover of haemoproteins in these patients.
It has been established [12-161 that, after injection of radiolabelled haem precursors (glycine and Gaminolaevulinic acid), maximum labelling of bilirubin occurs at approximately 120 days, consequent upon destruction of senescent erythrocytes. A fraction (approximately 10-26%) [ 12, 161 of labelled pigment appears in the blood within a few days of injection, and is referred to as early labelled bilirubin. Early glycine incorporation has two components: the first is thought to be largely of hepatic origin, the second is a by-product of erythropoiesis 1141. &Amino-laevulinic acid, which penetrates poorly into erythrocyte haem, is the preferential precursor of non-erythroid sources of bile pigment [ 
151.
In this paper we report studies on the kinetics of bilirubin in a large group of patients with Gilbert's syndrome carried out in order to investigate the proportion of patients having an increased bilirubin turnover. In some of these patients we have examined the haem sources of early labelled bilirubin formation, particularly the initial non-erythropoietic phase, by studying the early labelled peaks of bilirubin formation after injection of I 14Clglycine and N3H1amino-laevulinic acid. The two tracers were administered simultaneously in order to determine the relationship between the two sources of the early labelled peaks.
Materials and methods

Subjects
Non-radioactive bilirubin kinetics were studied in 100 patients with Gilbert's syndrome (77 males and 23 females, mean age 24 k 8 years) and nine normal volunteers (six males and three females, mean age 22 k 5 years). All patients were admitted to hospital with a history of periodic scleral icterus due to unconjugated hyperbilirubinaemia (higher than 2 mg/dl). Other liver function tests were normal, and overt haemolysis was excluded by routine tests (haemoglobin, packed cell volume, erythrocyte morphology, reticulocyte count, erythrocyte osmotic fragility, haemoglobin electrophoresis, glucose 6-phosphate dehydrogenase assay and Coomb's antiglobulin test).
Ten of the patients with Gilbert's syndrome and four of the normal volunteers, randomly selected from the above-mentioned subjects, were submitted to further investigation in order to estimate the production of the early labelled peak of bilirubin from [ 14Clglycine and G[3Hlamino-laevulinic acid.
This study was performed with the fully informed consent of each subject.
Protocol
Non-radioactive bilirubin kinetics. Studies were begun at 09.00 hours after an overnight fast in patients who had been medication free at least 1 month. Crystalline bilirubin (Merck, provided by Boehringer, S.P.A., Milano, Italy), 2 mg/kg body wt., dissolved in sodium carbonate solution (0.1 mol/l) [ Venous samples were collected after 1, 6 and 12 h and 1, 2, 3, 4, 5 and 6 days after the injection. Unconjugated labelled bilirubin was separated by chromatography in all samples with chloroform as eluent [ 151. A thin-layer chromatographic analysis, performed on a total of six samples obtained from six different studied subjects, using propan-l-ol/butan-1 -ol/acetic acid/water (30 : 40 : 1 : 29, by vol.) as solvent mixture and methanolic diazo reagent (1 : 1, v/v) as chromogen biliary pigment [2 11 revealed that the radioactivity recovered from the chloroform fraction migrated as authentic unconjugated bilirubin. 'H and I4C radioactivity counts were recorded twice (for 5 min each time) for each sample by a three-channel liquid scintillation counter (Packard Tri-Carb). All samples were re-counted after the addition of I4C-labelled internal standard, and further counted after addition of 3H-labelled internal standard to enable appropriate corrections for quenching.
The mean 5 min background count provided 204 counts (SD 12) for 14C and 127 counts (SD 16) for 3H, and the minimum counts per sample for 14C and for 3H were respectively 1 1 and 20 times higher than background. Because of the low yield of bilirubin from plasma in normal subjects, the radioactivity was expressed as d.p.m./ml of plasma and not as specific radioactivity as described before in the method 1151, in order to avoid possible underestimation. 
Results
Non-radioactive bilirubin kinetics
Plasma bilirubin clearance curves were resolved into two exponential functions, and the discriminating variable between controls and blood and Ko2 (min-') corresponds to bilirubin conjugation and excretion into bile. CBR (ml min-I kg-') is the volume of plasma cleared from bilirubin in 1 min and BRT (mg day-' kg-l) represents the daily turnover of bilirubin, slightly underestimating the daily production rate of bilirubin.
In normal volunteers the mean values for model-dependent and -independent parameters -
Mean values k SD of model-independent parameters calculated from the plasma clearance curves of non-radioactive unconjugated bilirubin in control subjects (C), and in Gilbert'ssyndrome patients group 1 (G I) and group 2 (G 11). BRT, Bilirubin turnover rate; CBR, hepatic bilirubin clearance; R240, percentage retention of exogenous bilirubin at 4 h. Mean and SD of baseline plasma unconjugated bilirubin are shown in the right panel. Variance analysis between G I and G I1 is represented by *P < 0.01 and **P < 0.005.
Mean values of the fractional transfer rates calculated from the plasma disappearance curves of non-radioactive unconjugated bilirubin according to the two-compartment model (model-dependent parameters) in control subjects (C), and in Gilbert'ssyndrome patients group 1 (G I) and group 2 (G 11).
According to the selected model, K,, (uptake) represents bilirubin transferred from the blood to the liver, K,, (reflux) is the bilirubin transferred from liver to blood, and KO, (conjugation) represents the conjugation-excretion into bile. Variance analysis between groups is represented by *P < 0.05, **P < 0.01 and ***P < 0.005.
mg day-' kg-I). On the basis of BRT values, patients with Gilbert's syndrome were divided in two groups: group 1 having normal BRT and group 2 having increased BRT, higher than 6 mg day-' kg-I. Patients in group 2 had higher baseline levels of unconjugated bilirubin than those in group 1 (mean & Model-dependent parameters (Fig. 2) in group 1 were characterized by decreasing uptake (K21) (P < 0.005) and conjugation (KO,) (P < 0.01) in comparison with controls, and group 2 had normal hepatic uptake by the liver and conjugation was decreased. Both groups had increased reflux ( K , , ) in comparison with control subjects and, in particular, the reflux rate of Gilbert's-syndrome patients in group 2 was significantly higher than that of group 1 (P < 67 -t 16%). This apparent discrepancy indicates that the differences of K,, values between groups were simply related to the different rates of uptake and conjugation in these groups. Representative plasma bilirubin clearances in the two groups, shown in Fig. 3 , illustrate the greater clearances in group 2 compared with group 1. Table 1 shows the parameters of the plasma non-radioactive bilirubin kinetics and the baseline unconjugated bilirubin levels of normal volunteers (four) and of Gilbert's patients (ten) selected at random for early pigment production studies.
Early labelled peaks
One hour after the injection of the tracers, both normal subjects (four) and patients with Gilbert's syndrome of group 1 (four) had a sharp peak of [ 14C)bilirubin, reaching the maximum value at 24h, followed by a brief decline and then a progressive rise that reached the maximum value at day 4 (Fig. 4) . The peak of [3Hlbilirubin from &[ 3H]aminolaevulinic acid appeared earlier in the blood, reaching the maximum value after 12 h, and then fell rapidly, declining to a baseline level by day 3 in both normal subjects and patients with Gilbert's syndrome group 1 (Fig. 4) . The amount of &[ 3Hlaminolaevulinic acid incorporation into early labelled bilirubin was much higher than that observed with [''Clglycine, as previously described [241. In four of the six patients, classified on the basis of BRT as belonging to group 2 (Fig. S) , the first component of the early peak of [l4C1bilirubin appeared earlier than that in controls, reaching values 39% higher (P < 0401), whereas the second peak was similar in amplitude but appeared earlier, i.e. on I la' day 3. The early peak of [3Hlbilirubin (Fig. 5 ) was respectively 28% and 26% higher than in controls and in group 1 (P < 0.001). The other two patients of group 2 had a normal I3H1-bilirubin peak, but they were different with respect to 14Clglycine incorporation. The l4C1-bilirubin early peak was characterized by a single curve having a single high peak (maximum at day 3) (Fig. 5) .
In order to establish whether the described rise of plasma labelled bilirubin in Gilbert's-syndrome patients was proportional to the reflux rate of the non-radioactive bilirubin and specifically related to this phenomenon, both the K,, values and the percentage ratio of reflux in Gilbert's-syndrome patients (ten) were tested by linear regression analysis against the maximum value of l3H1-bilirubin (1 2 h), and no significant correlations were demonstrable ( K 1 2 : r = 0.2446; percentage ratio of reflux: R = 0.2290).
Discussion
The data derived from our extensive study on non-radioactive bilirubin kinetics confirm the existence of two different populations in Gilbert's syndrome with respect to the daily turnover of bilirubin (BRT) 110, 22, 231. Although the syndrome is generally characterized by a normal rate of bilirubin production, in some cases, assuming that BRT only slightly underestimates the total bilirubin production 1251, the defect is associated with an increased daily production of the pigment. According to previous reports 122, 231, it is noteworthy that group 2 patients with increased BRT had a conjugation defect ( K O 2 ) with normal hepatic bilirubin uptake (K21), whereas patients in group 1 showed a defect in both uptake and conjugation. Moreover, group 2 had higher values for hepatic bilirubin clearance (CBR) and significantly lower 4 h retention (R240) in comparison with group 1. In spite of this, the defect in group 2 was accompanied by higher baseline levels of unconjugated bilirubin in the blood. From the analysis of dependent and independent variables it seems likely that these patients (group 2) had a simpler defect in bilirubin metabolism in respect of conjugation, but complicated by superimposed factors inducing higher levels of bilirubin in the blood.
Bilirubin overproduction in Gilbert's syndrome has been attributed to a mild compensated haemolytic state, as documented by erythrocyte survival studies or by an association with spherocytosis [9, 101.
When the early peaks of radiolabelled bile pigments were studied in patients with Gilbert's syndrome, it was found that patients in group 1 had normal incorporation of the labelled precursors, and patients of group 2 had increased incorporation. Within limitations imposed by the small number of studies, the linear regression analysis seems to exclude any correlation between the reflux rate of non-radioactive bilirubin and an increased proportion of incorporation of the tracers. On the other hand, the observation that Gilbert's-syndrome patients group 2 had an increased incorporation of tracers, involving in some cases one tracer and in some others both of them, adds support to these changes being related to other factors. Indeed, in group 2 two cases showed increased [ I4C lglycine incorporation and normal &[ 3H]aminolaevulinic acid incorporation. The profile of the specific ['*CIbilirubin radioactivity was characterized by an enlargement and heightening of the second peak, reaching a fusion with the first component. The high [ l4C]bi1irubin peak, in association with a normal [ 3H]bilirubin peak is attributable to an increased direct metabolic shunt from haem precursors to bilirubin in bone marrow, and is characteristic of the pattern found in ineffective erythropoiesis of the primary shunt hyperbilirubinaemia type [ 151. In contrast, in the other four patients of group 2, the increase in the first component of [I4Cl-bilirubin followed by the normality of the second peak, together with an increase in &13Hlamino-laevulinic acid incorporation, is compatible with an increased turnover of haem enzymes in the liver. This would be in keeping with the increase in catalase and hypertrophy of the hepatocyte smooth endoplasmic reticulum described in some cases of Gilbert's syndrome [26,271.
Leaving aside the two cases of Gilbert's syndrome associated with primary shunt hyperbilirubinaemia, we can offer only a tentative explanation for the alterations of the early pigment production in the four patients in group 2.
The increased incorporation of &[ 3Hlamino-laevulinic acid into the early labelled peak of bilirubin [ 13, 281 together with the ultrastructural and biochemical changes in the hepatocyte previously described [26,271 are similar to those seen in liver after enzyme induction by phenobarbital or by ethanol. However, the four patients studied were receiving no medication and were not consuming ethanol. It is thus possible that the increase in activities of haem enzyme in these cases of Gilbert's syndrome may represent an adaptive phenomenon to expedite the conversion of lipid-soluble compounds into more water-soluble forms. The phenomenon may represent an unsuccessful attempt to eliminate lipofuscin pigment that sometimes accumulates in the liver in Gilbert's syndrome [29] and/or an attempt to provide some additional enzymes for bilirubin conjugation.
The present study therefore provides biochemical confirmation of the previously reported abnormalities in bilirubin production in Gilbert's syndrome, but underlines the presence of a sub-population with increased synthesis of haem enzymes in the liver.
